Interest Expense, net (Details Narrative) - USD ($) |
Jun. 30, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|---|---|---|---|
| [custom:ContractAsset-0] | $ (179,000) | $ (358,000) | $ (716,000) |
| [custom:StartupCostFinancing-0] | $ 7,300,000 | $ 7,300,000 | $ 7,300,000 |
| Legal settlements receivable percentage | 50.00% | 50.00% | |
| Biofrontera AG [Member] | |||
| Debt Instrument, Interest Rate, Stated Percentage | 6.00% | 6.00% | |
| Other Receivables | $ 3,700,000 | $ 6,100,000 | |
| Legal settlements receivable percentage | 50.00% | ||
| Cutanea Acquisition Agreement [Member] | Maruho Co, Ltd. [Member] | |||
| Debt Instrument, Interest Rate, Stated Percentage | 6.00% | ||
| Other Receivables | $ 0 | ||
| Maruho Co, Ltd. [Member] | Cutanea Acquisition Agreement [Member] | |||
| [custom:ContractAsset-0] | $ 1,700,000 | 1,700,000 | |
| [custom:StartupCostFinancing-0] | $ 7,300,000 | $ 7,300,000 | |
| Debt Instrument, Interest Rate, Stated Percentage | 6.00% | ||
| Long-Term Debt, Maturity Date | Dec. 31, 2023 | Dec. 31, 2023 | |
| Biofrontera AG [Member] | |||
| Legal settlements receivable percentage | 50.00% |